The Future Is Now: Are You Keeping Pace With Oligo Synthesis Optimization?

The oligonucleotide therapeutics market is accelerating, with 20 approved treatments and a vast pipeline of future therapies emerging. While traditionally focused on rare diseases, new blockbusters are addressing larger patient populations, driving a need for optimization and efficiency across the entire development and manufacturing lifecycle.

Maximize resource use and prepare for future demands by exploring recent innovations in RNA synthesis and the complete oligo workflow. Early, informed decisions regarding process development and scale-up can significantly impact manufacturing costs down the line. Learn how to future-proof your R&D and manufacturing processes by exploring key insights on oligo synthesis systems and product developments by accessing the full presentation.